nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2E1—type 2 diabetes mellitus	0.129	0.387	CbGaD
Flunitrazepam—CYP1A2—type 2 diabetes mellitus	0.123	0.369	CbGaD
Flunitrazepam—CYP3A4—type 2 diabetes mellitus	0.0815	0.244	CbGaD
Flunitrazepam—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.0627	0.129	CbGbCtD
Flunitrazepam—UGT1A3—Losartan—type 2 diabetes mellitus	0.0404	0.0831	CbGbCtD
Flunitrazepam—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0296	0.0608	CbGbCtD
Flunitrazepam—UGT2B7—Losartan—type 2 diabetes mellitus	0.0292	0.0601	CbGbCtD
Flunitrazepam—UGT1A1—Losartan—type 2 diabetes mellitus	0.0253	0.0519	CbGbCtD
Flunitrazepam—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0156	0.0321	CbGbCtD
Flunitrazepam—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0152	0.0314	CbGbCtD
Flunitrazepam—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0139	0.0287	CbGbCtD
Flunitrazepam—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0133	0.0273	CbGbCtD
Flunitrazepam—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0133	0.0273	CbGbCtD
Flunitrazepam—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.013	0.0267	CbGbCtD
Flunitrazepam—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0122	0.0252	CbGbCtD
Flunitrazepam—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0118	0.0243	CbGbCtD
Flunitrazepam—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0232	CbGbCtD
Flunitrazepam—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.011	0.0227	CbGbCtD
Flunitrazepam—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.011	0.0227	CbGbCtD
Flunitrazepam—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0102	0.0209	CbGbCtD
Flunitrazepam—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00995	0.0205	CbGbCtD
Flunitrazepam—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00983	0.0202	CbGbCtD
Flunitrazepam—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00899	0.0185	CbGbCtD
Flunitrazepam—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00889	0.0183	CbGbCtD
Flunitrazepam—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00887	0.0182	CbGbCtD
Flunitrazepam—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00841	0.0173	CbGbCtD
Flunitrazepam—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00836	0.0172	CbGbCtD
Flunitrazepam—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00811	0.0167	CbGbCtD
Flunitrazepam—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00801	0.0165	CbGbCtD
Flunitrazepam—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00709	0.0146	CbGbCtD
Flunitrazepam—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00679	0.014	CbGbCtD
Flunitrazepam—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00641	0.0132	CbGbCtD
Flunitrazepam—CYP2C19—Losartan—type 2 diabetes mellitus	0.00621	0.0128	CbGbCtD
Flunitrazepam—CYP1A2—Losartan—type 2 diabetes mellitus	0.00573	0.0118	CbGbCtD
Flunitrazepam—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00564	0.0116	CbGbCtD
Flunitrazepam—CYP2C9—Losartan—type 2 diabetes mellitus	0.00516	0.0106	CbGbCtD
Flunitrazepam—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00486	0.00999	CbGbCtD
Flunitrazepam—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00466	0.00958	CbGbCtD
Flunitrazepam—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00466	0.00958	CbGbCtD
Flunitrazepam—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0044	0.00906	CbGbCtD
Flunitrazepam—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00328	0.00675	CbGbCtD
Flunitrazepam—CYP3A4—Losartan—type 2 diabetes mellitus	0.003	0.00617	CbGbCtD
Flunitrazepam—TSPO—hindlimb—type 2 diabetes mellitus	0.00104	0.134	CbGeAlD
Flunitrazepam—TSPO—artery—type 2 diabetes mellitus	0.000636	0.0824	CbGeAlD
Flunitrazepam—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000524	0.00582	CcSEcCtD
Flunitrazepam—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.000513	0.00569	CcSEcCtD
Flunitrazepam—Fatigue—Tolazamide—type 2 diabetes mellitus	0.000505	0.0056	CcSEcCtD
Flunitrazepam—Sleep disorder—Irbesartan—type 2 diabetes mellitus	0.000498	0.00553	CcSEcCtD
Flunitrazepam—Angioedema—Rosiglitazone—type 2 diabetes mellitus	0.000497	0.00551	CcSEcCtD
Flunitrazepam—Feeling abnormal—Tolazamide—type 2 diabetes mellitus	0.000483	0.00535	CcSEcCtD
Flunitrazepam—Sleep disorder—Losartan—type 2 diabetes mellitus	0.000469	0.0052	CcSEcCtD
Flunitrazepam—Fatigue—Nateglinide—type 2 diabetes mellitus	0.000468	0.00519	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Valsartan—type 2 diabetes mellitus	0.000458	0.00508	CcSEcCtD
Flunitrazepam—Hallucination—Bromocriptine—type 2 diabetes mellitus	0.000458	0.00508	CcSEcCtD
Flunitrazepam—Rash—Miglitol—type 2 diabetes mellitus	0.000451	0.00501	CcSEcCtD
Flunitrazepam—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000451	0.005	CcSEcCtD
Flunitrazepam—Tremor—Glipizide—type 2 diabetes mellitus	0.000446	0.00495	CcSEcCtD
Flunitrazepam—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.000443	0.00491	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Glipizide—type 2 diabetes mellitus	0.000442	0.0049	CcSEcCtD
Flunitrazepam—Malaise—Glipizide—type 2 diabetes mellitus	0.000429	0.00476	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Pioglitazone—type 2 diabetes mellitus	0.000423	0.00469	CcSEcCtD
Flunitrazepam—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.000421	0.00467	CcSEcCtD
Flunitrazepam—Asthenia—Tolazamide—type 2 diabetes mellitus	0.00042	0.00466	CcSEcCtD
Flunitrazepam—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.000417	0.00462	CcSEcCtD
Flunitrazepam—Tremor—Glimepiride—type 2 diabetes mellitus	0.000416	0.00462	CcSEcCtD
Flunitrazepam—Malaise—Pioglitazone—type 2 diabetes mellitus	0.000411	0.00456	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Sitagliptin—type 2 diabetes mellitus	0.000411	0.00456	CcSEcCtD
Flunitrazepam—Agitation—Glimepiride—type 2 diabetes mellitus	0.000408	0.00453	CcSEcCtD
Flunitrazepam—UGT1A3—liver—type 2 diabetes mellitus	0.000406	0.0526	CbGeAlD
Flunitrazepam—Angioedema—Glimepiride—type 2 diabetes mellitus	0.000406	0.0045	CcSEcCtD
Flunitrazepam—Rash—Tolbutamide—type 2 diabetes mellitus	0.000406	0.0045	CcSEcCtD
Flunitrazepam—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.000405	0.00449	CcSEcCtD
Flunitrazepam—Anxiety—Glipizide—type 2 diabetes mellitus	0.000404	0.00448	CcSEcCtD
Flunitrazepam—Sweating—Gliclazide—type 2 diabetes mellitus	0.000404	0.00448	CcSEcCtD
Flunitrazepam—Headache—Tolbutamide—type 2 diabetes mellitus	0.000403	0.00447	CcSEcCtD
Flunitrazepam—Sleep disorder—Ramipril—type 2 diabetes mellitus	0.000402	0.00446	CcSEcCtD
Flunitrazepam—Discomfort—Glipizide—type 2 diabetes mellitus	0.0004	0.00444	CcSEcCtD
Flunitrazepam—Malaise—Sitagliptin—type 2 diabetes mellitus	0.000399	0.00443	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000394	0.00437	CcSEcCtD
Flunitrazepam—Confusional state—Glipizide—type 2 diabetes mellitus	0.000392	0.00434	CcSEcCtD
Flunitrazepam—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000389	0.00432	CcSEcCtD
Flunitrazepam—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000387	0.00429	CcSEcCtD
Flunitrazepam—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000387	0.00429	CcSEcCtD
Flunitrazepam—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000384	0.00425	CcSEcCtD
Flunitrazepam—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.000383	0.00424	CcSEcCtD
Flunitrazepam—Ataxia—Losartan—type 2 diabetes mellitus	0.000382	0.00423	CcSEcCtD
Flunitrazepam—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.00038	0.00422	CcSEcCtD
Flunitrazepam—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000377	0.00418	CcSEcCtD
Flunitrazepam—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.000376	0.00417	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000376	0.00416	CcSEcCtD
Flunitrazepam—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.000372	0.00413	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000371	0.00411	CcSEcCtD
Flunitrazepam—Amnesia—Ramipril—type 2 diabetes mellitus	0.00037	0.00411	CcSEcCtD
Flunitrazepam—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00037	0.0041	CcSEcCtD
Flunitrazepam—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000369	0.00409	CcSEcCtD
Flunitrazepam—Rash—Tolazamide—type 2 diabetes mellitus	0.000369	0.00409	CcSEcCtD
Flunitrazepam—UGT2B7—kidney—type 2 diabetes mellitus	0.000369	0.0478	CbGeAlD
Flunitrazepam—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.000369	0.00409	CcSEcCtD
Flunitrazepam—Agitation—Bromocriptine—type 2 diabetes mellitus	0.000368	0.00408	CcSEcCtD
Flunitrazepam—Headache—Tolazamide—type 2 diabetes mellitus	0.000367	0.00407	CcSEcCtD
Flunitrazepam—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000367	0.00407	CcSEcCtD
Flunitrazepam—Confusional state—Glimepiride—type 2 diabetes mellitus	0.000366	0.00405	CcSEcCtD
Flunitrazepam—Rash—Linagliptin—type 2 diabetes mellitus	0.000365	0.00405	CcSEcCtD
Flunitrazepam—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000365	0.00405	CcSEcCtD
Flunitrazepam—Headache—Linagliptin—type 2 diabetes mellitus	0.000363	0.00403	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.00036	0.00399	CcSEcCtD
Flunitrazepam—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000359	0.00398	CcSEcCtD
Flunitrazepam—Muscular weakness—Losartan—type 2 diabetes mellitus	0.000358	0.00397	CcSEcCtD
Flunitrazepam—Rash—Acarbose—type 2 diabetes mellitus	0.000355	0.00393	CcSEcCtD
Flunitrazepam—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000354	0.00393	CcSEcCtD
Flunitrazepam—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000354	0.00392	CcSEcCtD
Flunitrazepam—Drowsiness—Metformin—type 2 diabetes mellitus	0.000352	0.00391	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.00035	0.00389	CcSEcCtD
Flunitrazepam—Somnolence—Glipizide—type 2 diabetes mellitus	0.000345	0.00383	CcSEcCtD
Flunitrazepam—Tremor—Glyburide—type 2 diabetes mellitus	0.000343	0.00381	CcSEcCtD
Flunitrazepam—Rash—Nateglinide—type 2 diabetes mellitus	0.000342	0.00379	CcSEcCtD
Flunitrazepam—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000342	0.00379	CcSEcCtD
Flunitrazepam—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00034	0.00377	CcSEcCtD
Flunitrazepam—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000339	0.00376	CcSEcCtD
Flunitrazepam—Angioedema—Glyburide—type 2 diabetes mellitus	0.000335	0.00371	CcSEcCtD
Flunitrazepam—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000334	0.0037	CcSEcCtD
Flunitrazepam—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00033	0.00366	CcSEcCtD
Flunitrazepam—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000322	0.00357	CcSEcCtD
Flunitrazepam—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000321	0.00356	CcSEcCtD
Flunitrazepam—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000321	0.00356	CcSEcCtD
Flunitrazepam—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00032	0.00355	CcSEcCtD
Flunitrazepam—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000319	0.00354	CcSEcCtD
Flunitrazepam—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000318	0.00353	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000318	0.00353	CcSEcCtD
Flunitrazepam—UGT1A1—kidney—type 2 diabetes mellitus	0.000314	0.0406	CbGeAlD
Flunitrazepam—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000313	0.00347	CcSEcCtD
Flunitrazepam—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000312	0.00346	CcSEcCtD
Flunitrazepam—Tremor—Gliclazide—type 2 diabetes mellitus	0.000308	0.00342	CcSEcCtD
Flunitrazepam—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000307	0.0034	CcSEcCtD
Flunitrazepam—TSPO—islet of Langerhans—type 2 diabetes mellitus	0.000306	0.0396	CbGeAlD
Flunitrazepam—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00339	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000305	0.00338	CcSEcCtD
Flunitrazepam—Agitation—Gliclazide—type 2 diabetes mellitus	0.000302	0.00335	CcSEcCtD
Flunitrazepam—Confusional state—Glyburide—type 2 diabetes mellitus	0.000301	0.00334	CcSEcCtD
Flunitrazepam—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000301	0.00333	CcSEcCtD
Flunitrazepam—Sweating—Losartan—type 2 diabetes mellitus	0.0003	0.00333	CcSEcCtD
Flunitrazepam—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000299	0.00331	CcSEcCtD
Flunitrazepam—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000298	0.0033	CcSEcCtD
Flunitrazepam—Malaise—Gliclazide—type 2 diabetes mellitus	0.000297	0.00329	CcSEcCtD
Flunitrazepam—Rash—Repaglinide—type 2 diabetes mellitus	0.000296	0.00328	CcSEcCtD
Flunitrazepam—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000296	0.00328	CcSEcCtD
Flunitrazepam—Headache—Repaglinide—type 2 diabetes mellitus	0.000294	0.00326	CcSEcCtD
Flunitrazepam—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00325	CcSEcCtD
Flunitrazepam—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000291	0.00322	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000289	0.00321	CcSEcCtD
Flunitrazepam—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000282	0.00313	CcSEcCtD
Flunitrazepam—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00028	0.0031	CcSEcCtD
Flunitrazepam—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00028	0.0031	CcSEcCtD
Flunitrazepam—Hypotension—Glyburide—type 2 diabetes mellitus	0.000279	0.0031	CcSEcCtD
Flunitrazepam—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000279	0.0031	CcSEcCtD
Flunitrazepam—Asthenia—Glipizide—type 2 diabetes mellitus	0.000279	0.00309	CcSEcCtD
Flunitrazepam—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000278	0.00308	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000277	0.00307	CcSEcCtD
Flunitrazepam—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000277	0.00307	CcSEcCtD
Flunitrazepam—Angioedema—Valsartan—type 2 diabetes mellitus	0.000276	0.00306	CcSEcCtD
Flunitrazepam—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000274	0.00304	CcSEcCtD
Flunitrazepam—Angioedema—Orlistat—type 2 diabetes mellitus	0.000273	0.00303	CcSEcCtD
Flunitrazepam—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000271	0.003	CcSEcCtD
Flunitrazepam—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000269	0.00299	CcSEcCtD
Flunitrazepam—Malaise—Orlistat—type 2 diabetes mellitus	0.000269	0.00299	CcSEcCtD
Flunitrazepam—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000267	0.00296	CcSEcCtD
Flunitrazepam—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000262	0.00291	CcSEcCtD
Flunitrazepam—TSPO—retina—type 2 diabetes mellitus	0.000261	0.0338	CbGeAlD
Flunitrazepam—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00026	0.00288	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00026	0.00288	CcSEcCtD
Flunitrazepam—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000259	0.00288	CcSEcCtD
Flunitrazepam—Tremor—Metformin—type 2 diabetes mellitus	0.000258	0.00286	CcSEcCtD
Flunitrazepam—Sweating—Ramipril—type 2 diabetes mellitus	0.000257	0.00285	CcSEcCtD
Flunitrazepam—Dizziness—Glipizide—type 2 diabetes mellitus	0.000257	0.00285	CcSEcCtD
Flunitrazepam—Anxiety—Valsartan—type 2 diabetes mellitus	0.000256	0.00284	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000255	0.00283	CcSEcCtD
Flunitrazepam—Acenocoumarol—CYP1A2—type 2 diabetes mellitus	0.000255	0.114	CrCbGaD
Flunitrazepam—Anxiety—Orlistat—type 2 diabetes mellitus	0.000253	0.00281	CcSEcCtD
Flunitrazepam—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000252	0.00279	CcSEcCtD
Flunitrazepam—Discomfort—Orlistat—type 2 diabetes mellitus	0.000251	0.00279	CcSEcCtD
Flunitrazepam—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000251	0.00278	CcSEcCtD
Flunitrazepam—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000249	0.00276	CcSEcCtD
Flunitrazepam—Malaise—Metformin—type 2 diabetes mellitus	0.000248	0.00275	CcSEcCtD
Flunitrazepam—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000246	0.00273	CcSEcCtD
Flunitrazepam—TSPO—nephron tubule—type 2 diabetes mellitus	0.000246	0.0319	CbGeAlD
Flunitrazepam—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000246	0.00273	CcSEcCtD
Flunitrazepam—Rash—Glipizide—type 2 diabetes mellitus	0.000245	0.00272	CcSEcCtD
Flunitrazepam—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000245	0.00271	CcSEcCtD
Flunitrazepam—Headache—Glipizide—type 2 diabetes mellitus	0.000243	0.0027	CcSEcCtD
Flunitrazepam—Tremor—Irbesartan—type 2 diabetes mellitus	0.000243	0.0027	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000241	0.00267	CcSEcCtD
Flunitrazepam—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00024	0.00266	CcSEcCtD
Flunitrazepam—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00265	CcSEcCtD
Flunitrazepam—Agitation—Irbesartan—type 2 diabetes mellitus	0.000239	0.00265	CcSEcCtD
Flunitrazepam—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000239	0.00265	CcSEcCtD
Flunitrazepam—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000238	0.0309	CbGeAlD
Flunitrazepam—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000237	0.00263	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000236	0.00261	CcSEcCtD
Flunitrazepam—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000235	0.0026	CcSEcCtD
Flunitrazepam—Malaise—Irbesartan—type 2 diabetes mellitus	0.000234	0.0026	CcSEcCtD
Flunitrazepam—UGT2B7—liver—type 2 diabetes mellitus	0.000233	0.0302	CbGeAlD
Flunitrazepam—Headache—Pioglitazone—type 2 diabetes mellitus	0.000233	0.00259	CcSEcCtD
Flunitrazepam—Discomfort—Metformin—type 2 diabetes mellitus	0.000231	0.00257	CcSEcCtD
Flunitrazepam—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000231	0.00257	CcSEcCtD
Flunitrazepam—Hypotension—Valsartan—type 2 diabetes mellitus	0.00023	0.00256	CcSEcCtD
Flunitrazepam—Tremor—Losartan—type 2 diabetes mellitus	0.000229	0.00254	CcSEcCtD
Flunitrazepam—Rash—Glimepiride—type 2 diabetes mellitus	0.000229	0.00254	CcSEcCtD
Flunitrazepam—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000228	0.00253	CcSEcCtD
Flunitrazepam—Rash—Sitagliptin—type 2 diabetes mellitus	0.000228	0.00253	CcSEcCtD
Flunitrazepam—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000228	0.00252	CcSEcCtD
Flunitrazepam—GABRA2—cortex of kidney—type 2 diabetes mellitus	0.000228	0.0295	CbGeAlD
Flunitrazepam—Headache—Glimepiride—type 2 diabetes mellitus	0.000227	0.00252	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000227	0.00252	CcSEcCtD
Flunitrazepam—Headache—Sitagliptin—type 2 diabetes mellitus	0.000226	0.00251	CcSEcCtD
Flunitrazepam—Agitation—Losartan—type 2 diabetes mellitus	0.000225	0.00249	CcSEcCtD
Flunitrazepam—Angioedema—Losartan—type 2 diabetes mellitus	0.000223	0.00248	CcSEcCtD
Flunitrazepam—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000221	0.00245	CcSEcCtD
Flunitrazepam—TSPO—cardiovascular system—type 2 diabetes mellitus	0.000221	0.0286	CbGeAlD
Flunitrazepam—Malaise—Losartan—type 2 diabetes mellitus	0.00022	0.00244	CcSEcCtD
Flunitrazepam—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00022	0.00244	CcSEcCtD
Flunitrazepam—Somnolence—Valsartan—type 2 diabetes mellitus	0.000219	0.00243	CcSEcCtD
Flunitrazepam—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000218	0.00242	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000217	0.00241	CcSEcCtD
Flunitrazepam—TSPO—kidney—type 2 diabetes mellitus	0.000216	0.028	CbGeAlD
Flunitrazepam—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000216	0.0024	CcSEcCtD
Flunitrazepam—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000216	0.0024	CcSEcCtD
Flunitrazepam—TSPO—pancreas—type 2 diabetes mellitus	0.000215	0.0278	CbGeAlD
Flunitrazepam—Asthenia—Glyburide—type 2 diabetes mellitus	0.000214	0.00238	CcSEcCtD
Flunitrazepam—Fatigue—Valsartan—type 2 diabetes mellitus	0.000213	0.00236	CcSEcCtD
Flunitrazepam—TSPO—cortex of kidney—type 2 diabetes mellitus	0.000211	0.0273	CbGeAlD
Flunitrazepam—GABRA2—adipose tissue—type 2 diabetes mellitus	0.000211	0.0273	CbGeAlD
Flunitrazepam—Fatigue—Orlistat—type 2 diabetes mellitus	0.00021	0.00233	CcSEcCtD
Flunitrazepam—Hypotension—Metformin—type 2 diabetes mellitus	0.00021	0.00233	CcSEcCtD
Flunitrazepam—Anxiety—Losartan—type 2 diabetes mellitus	0.000207	0.0023	CcSEcCtD
Flunitrazepam—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000207	0.00229	CcSEcCtD
Flunitrazepam—Rash—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00229	CcSEcCtD
Flunitrazepam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00228	CcSEcCtD
Flunitrazepam—Discomfort—Losartan—type 2 diabetes mellitus	0.000206	0.00228	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000205	0.00227	CcSEcCtD
Flunitrazepam—Headache—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00227	CcSEcCtD
Flunitrazepam—Dry mouth—Losartan—type 2 diabetes mellitus	0.000203	0.00226	CcSEcCtD
Flunitrazepam—Confusional state—Losartan—type 2 diabetes mellitus	0.000201	0.00223	CcSEcCtD
Flunitrazepam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000201	0.00223	CcSEcCtD
Flunitrazepam—Somnolence—Metformin—type 2 diabetes mellitus	0.0002	0.00221	CcSEcCtD
Flunitrazepam—UGT1A1—liver—type 2 diabetes mellitus	0.000198	0.0257	CbGeAlD
Flunitrazepam—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000198	0.0022	CcSEcCtD
Flunitrazepam—Tremor—Ramipril—type 2 diabetes mellitus	0.000196	0.00218	CcSEcCtD
Flunitrazepam—TSPO—adipose tissue—type 2 diabetes mellitus	0.000195	0.0252	CbGeAlD
Flunitrazepam—Tachycardia—Losartan—type 2 diabetes mellitus	0.000195	0.00216	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000194	0.00216	CcSEcCtD
Flunitrazepam—Fatigue—Metformin—type 2 diabetes mellitus	0.000194	0.00215	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000193	0.00214	CcSEcCtD
Flunitrazepam—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000193	0.00214	CcSEcCtD
Flunitrazepam—Agitation—Ramipril—type 2 diabetes mellitus	0.000193	0.00214	CcSEcCtD
Flunitrazepam—Angioedema—Ramipril—type 2 diabetes mellitus	0.000191	0.00212	CcSEcCtD
Flunitrazepam—Malaise—Ramipril—type 2 diabetes mellitus	0.000189	0.0021	CcSEcCtD
Flunitrazepam—Rash—Glyburide—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Flunitrazepam—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Flunitrazepam—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000188	0.00209	CcSEcCtD
Flunitrazepam—Headache—Glyburide—type 2 diabetes mellitus	0.000187	0.00208	CcSEcCtD
Flunitrazepam—Hypotension—Losartan—type 2 diabetes mellitus	0.000186	0.00207	CcSEcCtD
Flunitrazepam—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000185	0.00205	CcSEcCtD
Flunitrazepam—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000183	0.00203	CcSEcCtD
Flunitrazepam—Anxiety—Ramipril—type 2 diabetes mellitus	0.000178	0.00197	CcSEcCtD
Flunitrazepam—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000178	0.00197	CcSEcCtD
Flunitrazepam—Somnolence—Losartan—type 2 diabetes mellitus	0.000177	0.00197	CcSEcCtD
Flunitrazepam—Asthenia—Valsartan—type 2 diabetes mellitus	0.000177	0.00196	CcSEcCtD
Flunitrazepam—Discomfort—Ramipril—type 2 diabetes mellitus	0.000176	0.00196	CcSEcCtD
Flunitrazepam—Asthenia—Orlistat—type 2 diabetes mellitus	0.000175	0.00194	CcSEcCtD
Flunitrazepam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000175	0.00194	CcSEcCtD
Flunitrazepam—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000174	0.00194	CcSEcCtD
Flunitrazepam—Confusional state—Ramipril—type 2 diabetes mellitus	0.000172	0.00191	CcSEcCtD
Flunitrazepam—Fatigue—Losartan—type 2 diabetes mellitus	0.000172	0.00191	CcSEcCtD
Flunitrazepam—Rash—Gliclazide—type 2 diabetes mellitus	0.000169	0.00188	CcSEcCtD
Flunitrazepam—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000169	0.00188	CcSEcCtD
Flunitrazepam—Acenocoumarol—CYP3A4—type 2 diabetes mellitus	0.000169	0.0757	CrCbGaD
Flunitrazepam—Headache—Gliclazide—type 2 diabetes mellitus	0.000168	0.00187	CcSEcCtD
Flunitrazepam—CYP2A6—liver—type 2 diabetes mellitus	0.000167	0.0216	CbGeAlD
Flunitrazepam—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000167	0.00185	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000165	0.00183	CcSEcCtD
Flunitrazepam—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000164	0.00182	CcSEcCtD
Flunitrazepam—Dizziness—Valsartan—type 2 diabetes mellitus	0.000163	0.00181	CcSEcCtD
Flunitrazepam—Dizziness—Orlistat—type 2 diabetes mellitus	0.000161	0.00179	CcSEcCtD
Flunitrazepam—Asthenia—Metformin—type 2 diabetes mellitus	0.000161	0.00179	CcSEcCtD
Flunitrazepam—Hypotension—Ramipril—type 2 diabetes mellitus	0.00016	0.00177	CcSEcCtD
Flunitrazepam—Rash—Valsartan—type 2 diabetes mellitus	0.000156	0.00172	CcSEcCtD
Flunitrazepam—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000155	0.00172	CcSEcCtD
Flunitrazepam—Headache—Valsartan—type 2 diabetes mellitus	0.000155	0.00171	CcSEcCtD
Flunitrazepam—Rash—Orlistat—type 2 diabetes mellitus	0.000154	0.0017	CcSEcCtD
Flunitrazepam—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000154	0.0017	CcSEcCtD
Flunitrazepam—Headache—Orlistat—type 2 diabetes mellitus	0.000153	0.00169	CcSEcCtD
Flunitrazepam—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000152	0.00169	CcSEcCtD
Flunitrazepam—Somnolence—Ramipril—type 2 diabetes mellitus	0.000152	0.00169	CcSEcCtD
Flunitrazepam—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000152	0.0196	CbGeAlD
Flunitrazepam—Dizziness—Metformin—type 2 diabetes mellitus	0.000149	0.00165	CcSEcCtD
Flunitrazepam—Fatigue—Ramipril—type 2 diabetes mellitus	0.000147	0.00164	CcSEcCtD
Flunitrazepam—Acenocoumarol—ALB—type 2 diabetes mellitus	0.000147	0.066	CrCbGaD
Flunitrazepam—Asthenia—Losartan—type 2 diabetes mellitus	0.000143	0.00159	CcSEcCtD
Flunitrazepam—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000142	0.0184	CbGeAlD
Flunitrazepam—Rash—Metformin—type 2 diabetes mellitus	0.000142	0.00157	CcSEcCtD
Flunitrazepam—Dermatitis—Metformin—type 2 diabetes mellitus	0.000141	0.00157	CcSEcCtD
Flunitrazepam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000141	0.00156	CcSEcCtD
Flunitrazepam—Headache—Metformin—type 2 diabetes mellitus	0.000141	0.00156	CcSEcCtD
Flunitrazepam—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00014	0.00155	CcSEcCtD
Flunitrazepam—TSPO—liver—type 2 diabetes mellitus	0.000137	0.0177	CbGeAlD
Flunitrazepam—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000136	0.0176	CbGeAlD
Flunitrazepam—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000135	0.0175	CbGeAlD
Flunitrazepam—Rash—Irbesartan—type 2 diabetes mellitus	0.000134	0.00148	CcSEcCtD
Flunitrazepam—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000134	0.00148	CcSEcCtD
Flunitrazepam—CYP2B6—kidney—type 2 diabetes mellitus	0.000133	0.0172	CbGeAlD
Flunitrazepam—Headache—Irbesartan—type 2 diabetes mellitus	0.000133	0.00147	CcSEcCtD
Flunitrazepam—Dizziness—Losartan—type 2 diabetes mellitus	0.000132	0.00146	CcSEcCtD
Flunitrazepam—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000129	0.058	CrCbGaD
Flunitrazepam—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000128	0.0165	CbGeAlD
Flunitrazepam—Rash—Losartan—type 2 diabetes mellitus	0.000126	0.00139	CcSEcCtD
Flunitrazepam—Dermatitis—Losartan—type 2 diabetes mellitus	0.000126	0.00139	CcSEcCtD
Flunitrazepam—CYP2E1—kidney—type 2 diabetes mellitus	0.000125	0.0162	CbGeAlD
Flunitrazepam—Headache—Losartan—type 2 diabetes mellitus	0.000125	0.00139	CcSEcCtD
Flunitrazepam—Asthenia—Ramipril—type 2 diabetes mellitus	0.000123	0.00136	CcSEcCtD
Flunitrazepam—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000122	0.0158	CbGeAlD
Flunitrazepam—Dizziness—Ramipril—type 2 diabetes mellitus	0.000113	0.00125	CcSEcCtD
Flunitrazepam—Rash—Ramipril—type 2 diabetes mellitus	0.000108	0.0012	CcSEcCtD
Flunitrazepam—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000108	0.00119	CcSEcCtD
Flunitrazepam—CYP2C19—liver—type 2 diabetes mellitus	0.000108	0.0139	CbGeAlD
Flunitrazepam—Headache—Ramipril—type 2 diabetes mellitus	0.000107	0.00119	CcSEcCtD
Flunitrazepam—Ketazolam—CYP3A4—type 2 diabetes mellitus	0.000101	0.0453	CrCbGaD
Flunitrazepam—CYP3A4—kidney—type 2 diabetes mellitus	0.000101	0.013	CbGeAlD
Flunitrazepam—Nitrazepam—CYP2E1—type 2 diabetes mellitus	9.39e-05	0.042	CrCbGaD
Flunitrazepam—Ketazolam—ALB—type 2 diabetes mellitus	8.83e-05	0.0395	CrCbGaD
Flunitrazepam—CYP1A2—liver—type 2 diabetes mellitus	8.78e-05	0.0114	CbGeAlD
Flunitrazepam—CYP2B6—liver—type 2 diabetes mellitus	8.42e-05	0.0109	CbGeAlD
Flunitrazepam—Flurazepam—CYP2E1—type 2 diabetes mellitus	8.34e-05	0.0374	CrCbGaD
Flunitrazepam—CYP2C9—liver—type 2 diabetes mellitus	8.34e-05	0.0108	CbGeAlD
Flunitrazepam—Clonazepam—CYP3A4—type 2 diabetes mellitus	8.15e-05	0.0365	CrCbGaD
Flunitrazepam—CYP2E1—liver—type 2 diabetes mellitus	7.9e-05	0.0102	CbGeAlD
Flunitrazepam—Midazolam—CYP2E1—type 2 diabetes mellitus	7.74e-05	0.0347	CrCbGaD
Flunitrazepam—Clotiazepam—CYP3A4—type 2 diabetes mellitus	7.57e-05	0.0339	CrCbGaD
Flunitrazepam—Alprazolam—CYP3A4—type 2 diabetes mellitus	7.15e-05	0.032	CrCbGaD
Flunitrazepam—Clobazam—CYP3A4—type 2 diabetes mellitus	7.15e-05	0.032	CrCbGaD
Flunitrazepam—Clonazepam—ALB—type 2 diabetes mellitus	7.11e-05	0.0319	CrCbGaD
Flunitrazepam—Quazepam—CYP3A4—type 2 diabetes mellitus	6.93e-05	0.0311	CrCbGaD
Flunitrazepam—Diazepam—CYP2E1—type 2 diabetes mellitus	6.63e-05	0.0297	CrCbGaD
Flunitrazepam—CYP3A4—liver—type 2 diabetes mellitus	6.36e-05	0.00823	CbGeAlD
Flunitrazepam—Diazepam—CYP1A2—type 2 diabetes mellitus	6.31e-05	0.0283	CrCbGaD
Flunitrazepam—Estazolam—CYP3A4—type 2 diabetes mellitus	6.12e-05	0.0274	CrCbGaD
Flunitrazepam—Nitrazepam—CYP3A4—type 2 diabetes mellitus	5.91e-05	0.0265	CrCbGaD
Flunitrazepam—Adinazolam—CYP3A4—type 2 diabetes mellitus	5.83e-05	0.0261	CrCbGaD
Flunitrazepam—Prazepam—CYP3A4—type 2 diabetes mellitus	5.64e-05	0.0253	CrCbGaD
Flunitrazepam—Flurazepam—CYP3A4—type 2 diabetes mellitus	5.25e-05	0.0235	CrCbGaD
Flunitrazepam—Triazolam—CYP3A4—type 2 diabetes mellitus	5.25e-05	0.0235	CrCbGaD
Flunitrazepam—Temazepam—CYP3A4—type 2 diabetes mellitus	5.02e-05	0.0225	CrCbGaD
Flunitrazepam—Midazolam—CYP3A4—type 2 diabetes mellitus	4.87e-05	0.0218	CrCbGaD
Flunitrazepam—Diazepam—CYP3A4—type 2 diabetes mellitus	4.17e-05	0.0187	CrCbGaD
Flunitrazepam—Diazepam—ALB—type 2 diabetes mellitus	3.64e-05	0.0163	CrCbGaD
Flunitrazepam—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.11e-06	5.16e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.11e-06	5.16e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.11e-06	5.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.11e-06	5.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.09e-06	5.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	4.09e-06	5.14e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.08e-06	5.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	4.08e-06	5.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	4.08e-06	5.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.06e-06	5.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.06e-06	5.1e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.03e-06	5.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.03e-06	5.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	4.02e-06	5.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.01e-06	5.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.01e-06	5.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	3.99e-06	5.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.97e-06	4.99e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	3.95e-06	4.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.94e-06	4.95e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	3.94e-06	4.94e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	3.93e-06	4.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	3.9e-06	4.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	3.89e-06	4.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	3.87e-06	4.86e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.86e-06	4.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	3.83e-06	4.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	3.82e-06	4.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	3.8e-06	4.77e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.79e-06	4.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.79e-06	4.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.77e-06	4.74e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.77e-06	4.73e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	3.76e-06	4.72e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.76e-06	4.72e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.74e-06	4.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.74e-06	4.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	3.73e-06	4.68e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	3.72e-06	4.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.71e-06	4.65e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.69e-06	4.63e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.69e-06	4.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.67e-06	4.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.65e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	3.65e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	3.65e-06	4.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	3.64e-06	4.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.63e-06	4.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.62e-06	4.55e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.62e-06	4.54e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.62e-06	4.54e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.6e-06	4.52e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.6e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.6e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.6e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.59e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.59e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.59e-06	4.51e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.57e-06	4.49e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.57e-06	4.49e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.56e-06	4.47e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	3.54e-06	4.45e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.51e-06	4.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.5e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.49e-06	4.39e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.47e-06	4.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.47e-06	4.35e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.45e-06	4.33e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.44e-06	4.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.43e-06	4.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.41e-06	4.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.41e-06	4.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	3.37e-06	4.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	3.36e-06	4.21e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.35e-06	4.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.33e-06	4.18e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.31e-06	4.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	3.31e-06	4.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	3.29e-06	4.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.29e-06	4.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.27e-06	4.11e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.27e-06	4.11e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.24e-06	4.06e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.23e-06	4.05e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.23e-06	4.05e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.23e-06	4.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.22e-06	4.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	3.19e-06	4e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.17e-06	3.97e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.14e-06	3.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	3.14e-06	3.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	3.12e-06	3.92e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.12e-06	3.92e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.11e-06	3.91e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.09e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.09e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.09e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	3.09e-06	3.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.08e-06	3.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.07e-06	3.85e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.07e-06	3.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.06e-06	3.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.04e-06	3.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.03e-06	3.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.03e-06	3.8e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.95e-06	3.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.95e-06	3.7e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.92e-06	3.66e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.91e-06	3.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	2.9e-06	3.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.9e-06	3.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.87e-06	3.6e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.85e-06	3.57e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.85e-06	3.57e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.84e-06	3.57e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.83e-06	3.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.82e-06	3.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.82e-06	3.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.82e-06	3.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.81e-06	3.52e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.8e-06	3.51e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.8e-06	3.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.79e-06	3.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.78e-06	3.48e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.78e-06	3.48e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.78e-06	3.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.77e-06	3.48e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.76e-06	3.46e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-06	3.46e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.75e-06	3.45e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	3.42e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.71e-06	3.4e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.69e-06	3.38e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.68e-06	3.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.68e-06	3.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	3.35e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-06	3.35e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.65e-06	3.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.64e-06	3.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.62e-06	3.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.61e-06	3.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	3.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.54e-06	3.18e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.51e-06	3.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.51e-06	3.14e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	2.5e-06	3.14e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.49e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.49e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.49e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-06	3.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	2.45e-06	3.07e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.44e-06	3.07e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.44e-06	3.06e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.42e-06	3.04e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-06	3.03e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-06	3.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	3.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.41e-06	3.02e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-06	3.01e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.4e-06	3.01e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.37e-06	2.97e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.37e-06	2.97e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.37e-06	2.97e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.36e-06	2.96e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	2.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	2.94e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.33e-06	2.93e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	2.9e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.3e-06	2.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.29e-06	2.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.29e-06	2.88e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.28e-06	2.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	2.85e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.25e-06	2.83e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.25e-06	2.83e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.24e-06	2.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	2.76e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.19e-06	2.75e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	2.71e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.16e-06	2.71e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.16e-06	2.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	2.7e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-06	2.7e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-06	2.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	2.69e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	2.13e-06	2.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	2.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-06	2.63e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.09e-06	2.62e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-06	2.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.06e-06	2.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.02e-06	2.53e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.98e-06	2.48e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-06	2.43e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.88e-06	2.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	2.35e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.86e-06	2.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.86e-06	2.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.85e-06	2.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.85e-06	2.32e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.85e-06	2.32e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.84e-06	2.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	2.31e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.83e-06	2.29e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	2.28e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.77e-06	2.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-06	2.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-06	2.22e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.73e-06	2.17e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.73e-06	2.17e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.69e-06	2.13e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	2.12e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.66e-06	2.08e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.65e-06	2.07e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	2.03e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	2.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	2.02e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.61e-06	2.02e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	2.01e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.59e-06	1.99e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	1.97e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.53e-06	1.91e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.5e-06	1.88e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	1.85e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.45e-06	1.82e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	1.81e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.42e-06	1.79e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.42e-06	1.78e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.4e-06	1.76e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	1.73e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	1.73e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	1.67e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	1.58e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.24e-06	1.55e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.21e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.11e-06	1.4e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.35e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.06e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.06e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.05e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	9.73e-07	1.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	8.13e-07	1.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	7.41e-07	9.31e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	6.34e-07	7.95e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.89e-07	6.14e-06	CbGpPWpGaD
